Article
Cell Biology
Yulian Chen, Huanguo Jiang, Zhikun Zhan, Jindi Lu, Tanwei Gu, Ping Yu, Weimin Liang, Xi Zhang, Shuwen Liu, Huichang Bi, Shilong Zhong, Lan Tang
Summary: Regulating lipid metabolism balance to achieve a healthy lipid homeostasis may be a promising therapy for alleviating hepatosteatosis. Clinical studies have found that in obese patients with a body mass index (BMI) greater than 28, an increase in triglycerides (TG) is accompanied by a decrease in phosphatidylethanolamine (PE). Patients with high TG and low PE levels have shorter survival and poor prognosis.
CELL DEATH & DISEASE
(2023)
Article
Oncology
Lili Li, Shumin Hao, Meiling Gao, Junxiao Liu, Xin Xu, Jianfei Huang, Genhong Cheng, Heng Yang
Summary: This study demonstrates that class I HDAC inhibitors suppress tumor growth by enhancing anti-tumor immunity, contrary to previous belief that they directly affect tumor cell cycle and apoptosis.
CANCER IMMUNOLOGY RESEARCH
(2023)
Article
Environmental Sciences
Jyun-Lin Lee, Yao-Chien Wang, Yu-An Hsu, Chih-Sheng Chen, Rui-Cian Weng, Yen-Pei Lu, Chun-Yu Chuang, Lei Wan
Summary: Exposure to BPA can increase hepatic lipid uptake and promote NAFLD development by stimulating ROS-induced CD36 overexpression; moreover, using the ROS scavenger NAC can alleviate BPA-mediated HFCCD-induced lipid accumulation and steatohepatitis.
Article
Biology
Qingqing Guan, Zhaosu Chen, Fang Yu, Lingling Liu, Yuanyong Huang, Gang Wei, Cheng-Ming Chiang, Jiemin Wong, Jiwen Li
Summary: By using a series of MYC mutants, we found that MYC can promote global transcription and enhance serine 2 phosphorylation of RNA polymerase II C-terminal domain, even when deficient in DNA binding or known transcriptional activation activities. The ability of MYC mutants to promote global transcription and serine 2 phosphorylation correlates with their ability to suppress CDK9 SUMOylation and enhance positive transcription elongation factor b (P-TEFb) complex formation. Furthermore, MYC's activity in enhancing global transcription contributes to its activity in promoting cell proliferation and transformation.
SCIENCE CHINA-LIFE SCIENCES
(2023)
Article
Medicine, Research & Experimental
Guizhen Zhao, Ziyi Chang, Yang Zhao, Yanhong Guo, Haocheng Lu, Wenying Liang, Oren Rom, Huilun Wang, Jinjian Sun, Tianqing Zhu, Yanbo Fan, Lin Chang, Bo Yang, Minerva T. Garcia-Barrio, Y. Eugene Chen, Jifeng Zhang
Summary: The study indicates that endothelial KLF11 plays an important role in maintaining vascular homeostasis, with its deficiency exacerbating AAA formation and overexpression inhibiting AAA occurrence. KLF11 not only inhibits endothelial cell inflammatory response, but also reduces the production of reactive oxygen species, exerting a protective effect against AAA.
Article
Immunology
Bopei Li, Liang Liang, Yeyang Chen, Jinlu Liu, Zhen Wang, Yuantian Mao, Kun Zhao, Junqiang Chen
Summary: This study reveals the promotive role of circ_0008287 in gastric cancer progression and immune escape. It shows that circ_0008287, upregulated in gastric cancer cells, increases the viability, invasive and migratory potentials of cancer cells. Circ_0008287 competitively binds to miR-548c-3p, increasing the expression of CLIC1, which impairs the function of CD8+ T cells and promotes their apoptosis. Downregulation of circ_0008287 suppresses tumor formation and metastasis in vivo.
INTERNATIONAL IMMUNOPHARMACOLOGY
(2022)
Article
Multidisciplinary Sciences
Hanlin Lu, Peidong Yuan, Xiaoping Ma, Xiuxin Jiang, Shaozhuang Liu, Chang Ma, Sjaak Philipsen, Qunye Zhang, Jianmin Yang, Feng Xu, Cheng Zhang, Yun Zhang, Wencheng Zhang
Summary: ACE inhibitors are commonly used to treat cardiovascular diseases and promote angiogenesis. This study reveals that endothelial USP7-Sp1/Sp3-Notch1 signaling plays a central role in pathophysiological angiogenesis in response to ACE inhibitor treatment.
NATURE COMMUNICATIONS
(2023)
Article
Biochemistry & Molecular Biology
Yu-Chen Lee, Song-Chang Lin, Guoyu Yu, Ming Zhu, Jian H. Song, Keith Rivera, Darryl Pappin, Christopher J. Logothetis, Theocharis Panaretakis, Guocan Wang, Li-Yuan Yu-Lee, Sue-Hwa Lin
Summary: The study reveals that tumor-induced endothelial cells transitioning into osteoblasts lead to bone formation, enhancing the metastatic potential of prostate cancer cells. Tenascin C (TNC) is identified as a major protein secreted during this process, promoting prostate cancer cell migration through various signaling pathways. Targeting TNC may hold promise for prostate cancer therapy.
Article
Medicine, Research & Experimental
Hui Yang, Xiaocen Liu, Xiaolong Zhu, Xueqin Li, Lan Jiang, Min Zhong, Mengying Zhang, Tianbing Chen, Mingzhe Ma, Xiuming Liang, Kun Lv
Summary: CPVL is significantly upregulated in glioma cells and tissues, and its high expression is associated with advanced clinical grade and poor prognosis. Silencing CPVL promotes glioma cell apoptosis, inhibits cell proliferation, and suppresses tumorigenicity in vitro and in vivo, potentially through interactions with BTK and modulation of STAT1 phosphorylation.
Article
Physiology
Wei Yu, Qingchun Li, Tong Chen, Huaiyu Zhang, Xiaofeng Cui, Kexin Shen
Summary: The study identified a new pathway in gastric cancer progression and highlighted an important factor. However, inaccuracies in the data and its analysis led to the retraction of the article.
EXPERIMENTAL PHYSIOLOGY
(2021)
Article
Biochemistry & Molecular Biology
Zhenxing Zhang, Chao Chen, Fan Yang, Yi-Xin Zeng, Pengkai Sun, Ping Liu, Xinjian Li
Summary: A study has found that itaconate, an endogenous metabolite, functions as a lysosomal inducer in macrophages during bacterial infection. It activates the transcription factor TFEB by directly alkylating it, leading to increased lysosomal biogenesis and improved antibacterial ability. Inhibition of itaconate synthesis or expression of a mutant TFEB lacking alkylation impairs macrophage's antibacterial ability, while treatment with a cell-permeable itaconate derivative limits inflammation.
Article
Multidisciplinary Sciences
C. Kalogirou, J. Linxweiler, P. Schmucker, M. T. Snaebjornsson, W. Schmitz, S. Wach, M. Krebs, E. Hartmann, M. Puhr, A. Mueller, M. Spahn, A. K. Seitz, T. Frank, H. Marouf, G. Buechel, M. Eckstein, H. Kuebler, M. Eilers, M. Saar, K. Junker, F. Roehrig, B. Kneitz, M. T. Rosenfeldt, A. Schulze
Summary: The downregulation of miR-205 promotes cholesterol synthesis and androgen receptor signaling in aggressive prostate cancer by enhancing the expression of the rate-limiting enzyme squalene epoxidase. Overexpression of squalene epoxidase in advanced prostate cancer correlates with poor survival, indicating its potential as a therapeutic target. Inhibition of squalene epoxidase with terbinafine effectively blocked tumor growth in mice and reduced levels of prostate specific antigen in late-stage prostate cancer patients.
NATURE COMMUNICATIONS
(2021)
Article
Multidisciplinary Sciences
Heng Boon Low, Zhen Lim Wong, Bangyuan Wu, Li Ren Kong, Chin Wen Png, Yik-Lam Cho, Chun-Wei Li, Fengchun Xiao, Xuan Xin, Henry Yang, Jia Min Loo, Fiona Yi Xin Lee, Iain Bee Huat Tan, Ramanuj DasGupta, Han-Ming Shen, Herbert Schwarz, Nicholas R. J. Gascoigne, Boon Cher Goh, Xiaohong Xu, Yongliang Zhang
Summary: The study identifies DUSP16 as a regulator of chemoresistance in various cancers by impairing mitochondria-associated apoptosis. DUSP16 is proposed as a marker for chemotherapy sensitivity and treatment outcome, offering a potential therapeutic target for overcoming chemoresistance in cancer therapy.
NATURE COMMUNICATIONS
(2021)
Article
Immunology
Chuan Xiao, Qing Li, Jingjing Xiao, Xianjun Chen, Jia Yuan, Shuwen Li, Wei Li, Daixiu Gao, Lu Li, Ying Liu, Feng Shen
Summary: miR-9 improves alveolar hypercoagulation and fibrinolysis inhibition in ARDS by suppressing NF-κB pathway activation and directly targeting RUNX1, suggesting that miR-9/RUNX1 may be a potential therapeutic target for ARDS.
INTERNATIONAL IMMUNOPHARMACOLOGY
(2023)
Article
Cell Biology
Dong Ha Kim, Hyojeong Park, Yun Jung Choi, Myoung-Hee Kang, Tae-Keun Kim, Chan-Gi Pack, Chang-Min Choi, Jae Cheol Lee, Jin Kyung Rho
Summary: Exosomal miR-1260b promotes angiogenesis in HUVECs and metastasis in NSCLC by targeting HIPK2, and may serve as a potential prognostic marker for lung cancer.
CELL DEATH & DISEASE
(2021)